- The stock price of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) slightly increased pre-market today. This is why it happened.
The stock price of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) slightly increased pre-market today. Investors appear to be responding to a bullish research report.
Bernstein analyst Aaron Gal upgraded Regeneron Pharmaceuticals to an “Outperform” rating from a “Market Perform” rating. And Gal assigned the company a $660 price target.
Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.
